-

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into iRhythm Technologies, Inc. (IRTC)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) and certain of its officers and directors issued false and/or misleading statements and/or failed to disclose information pertinent to investors in violation of federal securities laws. If you purchased or otherwise own iRhythm securities, and have suffered a loss, you are encouraged to contact Jonathan Zimmerman at (888) 398-9312 for more information.

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services.

On May 30, 2023, iRhythm disclosed that on May 25, 2023, it had received a warning letter from the U.S. Food and Drug Administration (“FDA”), alleging non-conformities to regulations for medical devices, including medical device reporting requirements, related to the Company’s Zio AT System and medical device quality system requirements.

On this news, iRhythm's stock price fell $7.41 per share, or 6.09%, to close at $114.27 per share on May 31, 2023.

What You Can Do – CLICK HERE

If you purchased or otherwise own iRhythm securities and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Jonathan Zimmerman at (888) 398-9312, or at jzimmerman@scott-scott.com.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

Contacts

Scott+Scott Attorneys at Law LLP

NASDAQ:IRTC

Release Versions

Contacts

More News From Scott+Scott Attorneys at Law LLP

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Jayud Global Logistics Limited et al (NASDAQ: JYD)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Jayud Global Logistics Limited, Xiaogang Geng, Alan Tan Khim Guan, Lin Bao, Mengmeng Hu, Freidman, LLP, and Marcum Asia CPAs, LLP (collectively, the “Defendants”). The action, which was filed in the U.S. District Court for the Southern District of New York and captioned Lindstrom...

UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services’s Directors and Officers for Breach of Fiduciary Duties – UHS

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Universal Health Services, Inc. (NYSE: UHS) breached their fiduciary duties to Universal Health and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Universal Health’s board of directors or senior management failed to manage Universal Health in an acceptable manner, in br...

GREEN DOT INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Buyout by CommerceOne Financial Corporation and Smith Ventures of Green Dot Corporation – GDOT

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Green Dot Corporation (“Green Dot”) (NYSE: GDOT) breached their fiduciary duties to Green Dot’s shareholders in approving a buyout by CommerceOne Financial Corporation (“CommerceOne”) and Smith Ventures, LLC (“Smith Ventures”) for inadequate consideration. CLICK HERE TO LEARN MORE Scott+Scott is investigating whet...
Back to Newsroom